133 related articles for article (PubMed ID: 29404012)
1. Stability study on an anti-cancer drug 4-(3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid (CLEFMA) using a stability-indicating HPLC method.
Raghuvanshi D; Nkepang G; Hussain A; Yari H; Awasthi V
J Pharm Anal; 2017 Feb; 7(1):1-9. PubMed ID: 29404012
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of 4-[3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid, in a mouse model of lung cancer xenograft.
Yadav VR; Sahoo K; Awasthi V
Br J Pharmacol; 2013 Dec; 170(7):1436-48. PubMed ID: 24102070
[TBL] [Abstract][Full Text] [Related]
3. Cyclodextrin-mediated entrapment of curcuminoid 4-[3,5-bis(2-chlorobenzylidene-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid] or CLEFMA in liposomes for treatment of xenograft lung tumor in rats.
Agashe H; Sahoo K; Lagisetty P; Awasthi V
Colloids Surf B Biointerfaces; 2011 Jun; 84(2):329-37. PubMed ID: 21315563
[TBL] [Abstract][Full Text] [Related]
4. The curcuminoid CLEFMA selectively induces cell death in H441 lung adenocarcinoma cells via oxidative stress.
Sahoo K; Dozmorov MG; Anant S; Awasthi V
Invest New Drugs; 2012 Apr; 30(2):558-67. PubMed ID: 21181232
[TBL] [Abstract][Full Text] [Related]
5. Remediation of hemorrhagic shock-induced intestinal barrier dysfunction by treatment with diphenyldihaloketones EF24 and CLEFMA.
Yadav VR; Hussain A; Sahoo K; Awasthi V
J Pharmacol Exp Ther; 2014 Nov; 351(2):413-22. PubMed ID: 25204337
[TBL] [Abstract][Full Text] [Related]
6. CLEFMA-an anti-proliferative curcuminoid from structure-activity relationship studies on 3,5-bis(benzylidene)-4-piperidones.
Lagisetty P; Vilekar P; Sahoo K; Anant S; Awasthi V
Bioorg Med Chem; 2010 Aug; 18(16):6109-20. PubMed ID: 20638855
[TBL] [Abstract][Full Text] [Related]
7. CLEFMA Activates the Extrinsic and Intrinsic Apoptotic Processes through JNK1/2 and p38 Pathways in Human Osteosarcoma Cells.
Yang JS; Lin RC; Hsieh YH; Wu HH; Li GC; Lin YC; Yang SF; Lu KH
Molecules; 2019 Sep; 24(18):. PubMed ID: 31505816
[TBL] [Abstract][Full Text] [Related]
8. Induction of gut proteasome activity in hemorrhagic shock and its recovery by treatment with diphenyldihaloketones CLEFMA and EF24.
Rao G; Houson H; Nkepang G; Yari H; Teng C; Awasthi V
Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G318-G327. PubMed ID: 29746173
[TBL] [Abstract][Full Text] [Related]
9. Ultraviolet-photodiode array and high-performance liquid chromatographic/mass spectrometric studies on forced degradation behavior of glibenclamide and development of a validated stability-indicating method.
Bansal G; Singh M; Jindal KC; Singh S
J AOAC Int; 2008; 91(4):709-19. PubMed ID: 18727528
[TBL] [Abstract][Full Text] [Related]
10. Study of forced degradation behavior of enalapril maleate by LC and LC-MS and development of a validated stability-indicating assay method.
Bhardwaj SP; Singh S
J Pharm Biomed Anal; 2008 Jan; 46(1):113-20. PubMed ID: 17964751
[TBL] [Abstract][Full Text] [Related]
11. Characterization of stress degradation products of nintedanib by UPLC, UHPLC-Q-TOF/MS/MS and NMR: Evidence of a degradation product with a structure alert for mutagenicity.
Dhiman V; Balhara A; Singh S; Tiwari S; Gananadhamu S; Talluri MVNK
J Pharm Biomed Anal; 2021 May; 199():114037. PubMed ID: 33836462
[TBL] [Abstract][Full Text] [Related]
12. Degradation kinetics and mechanisms of moricizine hydrochloride in acidic medium.
King SP; Sigvardson KW; Dudzinski J; Torosian G
J Pharm Sci; 1992 Jun; 81(6):586-91. PubMed ID: 1522500
[TBL] [Abstract][Full Text] [Related]
13. Stability and degradation profiles of Spantide II in aqueous solutions.
Kikwai L; Babu RJ; Kanikkannan N; Singh M
Eur J Pharm Sci; 2006 Feb; 27(2-3):158-66. PubMed ID: 16266798
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive study on degradation profile of firocoxib and structural elucidation of its key degradation products.
Adhikari S; Tian J; Rustum AM
J Pharm Biomed Anal; 2023 Feb; 224():115192. PubMed ID: 36463770
[TBL] [Abstract][Full Text] [Related]
16. Degradation kinetics study of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) by a validated stability-indicating RP-HPLC method.
Kim KS; Yang ES; Kim DS; Kim DW; Yong CS; Kim JO; Jin SG; Choi HG
J Pharm Biomed Anal; 2018 Feb; 149():374-380. PubMed ID: 29145099
[TBL] [Abstract][Full Text] [Related]
17. Validated stability-indicating HPLC method for the determination of pridinol mesylate. Kinetics study of its degradation in acid medium.
Bianchini RM; Castellano PM; Kaufman TS
J Pharm Biomed Anal; 2008 Dec; 48(4):1151-60. PubMed ID: 18922659
[TBL] [Abstract][Full Text] [Related]
18. Characterization of degradation products of ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis.
Patel PN; Borkar RM; Kalariya PD; Gangwal RP; Sangamwar AT; Samanthula G; Ragampeta S
J Mass Spectrom; 2015 Feb; 50(2):344-53. PubMed ID: 25800016
[TBL] [Abstract][Full Text] [Related]
19. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method.
Bhutani H; Singh S; Vir S; Bhutani KK; Kumar R; Chakraborti AK; Jindal KC
J Pharm Biomed Anal; 2007 Mar; 43(4):1213-20. PubMed ID: 17118610
[TBL] [Abstract][Full Text] [Related]
20. Kinetics study of metaxalone degradation under hydrolytic, oxidative and thermal stress conditions using stability-indicating HPLC method.
Marothu VK; Dash RN; Vemula S; Donkena S; Devi R; Gorrepati M
J Pharm Anal; 2012 Dec; 2(6):431-436. PubMed ID: 29403778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
